- Global Pharma News & Resources

Global Dry Powder Inhaler Market Consumption Volume, Competitive Dynamics And Worldwide Overview 2028

Dry powder inhaler helps in the delivery of drug powder formulation of an active drug via pulmonary route into the lungs. Efficient drug delivery into the lungs is dependent on performance of drug delivery system and powder formulation. The drugs present in dry powder inhalers are blended with suitable carrier such as lactose which improves flow properties and dose uniformity. Dry powder requires a measured dose of powder ready to use by patient use. The device has an active dry powder fluidization mechanism which works in the low inhalation flow rates.

Availability of various features such as easy usage, compact form, highly reproducible fine particle dosing, minimal extra-pulmonary loss of drying and presence of multi-dose system are major factors driving growth of the dry powder inhaler market over the forecast period. Also, dry powder inhalers are better alternatives to the conventional inhalation devices such as pressurized metered dose inhalers as it does not contain propellant. Another factor contributing towards market growth is the increasing preference for convenience and easy handling of respiratory devices. Rising incidence rates of asthma across the globe is another factor fueling growth of the global market. According to World Health Organization, an estimated 235 million individuals suffered from asthma and around 383,000 deaths occurred worldwide in 2015.

However, device resistance and design issues related to dry powder inhalers can hamper market growth to a significant extent. Moreover, dry powder inhalers are expensive as compared to pressurized metered dose inhalers which is expected to restrain growth of the global dry powder inhaler market over the forecast period.

The global dry powder inhaler market is segmented on the basis of product type, application, and region. On the basis of region, the global dry powder inhaler market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Global Dry Powder Inhaler Market is segmented into:

By Product Type:

  • Single Dose Dry Powder Inhaler
  • Multiple Dose Dry Powder Inhaler

By Distribution Channel:

  • Hospital
  • Retail Pharmacies
  • Drug Stores
  • Others

By Application:

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Others

To Get Sample Copy of Report visit @

Asia Pacific market is projected to register fastest revenue CAGR over the forecast period, owing to rising demand for cost effective respiratory devices. Additionally, rising air pollution levels in countries such as China and India leading to larger number of respiratory disorders and lung problems is expected to further drive growth of the Asia Pacific market. North America is expected to account to account for highest market share in terms of revenue. This can be attributed to presence of prominent market players in this region. Europe market is projected to account for second-largest revenue share in the global market, followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively.

Key players operating in the global dry powder inhaler market are AstraZeneca PLC, GlaxoSmithKline plc, Vectura Group plc, Boehringer Ingelheim GmbH, Otsuka Pharmaceutical Co. Ltd., Cipla Inc., Teicos Pharma Ltd., Luckys Pharma, Norton Healthcare, Inc., and Respira Therapeutics, Inc.

Editor Details

Last Updated: 15-Feb-2019